NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism buff.ly/2Xgc3uw
Annual Report to the Nation: Overall cancer mortality continues to decline; Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men buff.ly/2EHxAWG
Study shows incidence rates of aggressive subtypes of uterine cancer rising buff.ly/2VTNgAR
Harnessing T-cell “stemness” could enhance cancer immunotherapy buff.ly/2TJ2HG6
AI approach outperformed human experts in identifying cervical precancer buff.ly/2Fq5sZd
BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk buff.ly/2FhHv7c
Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors buff.ly/2PRUfCq
Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia buff.ly/2AOFJpI
Statement from NCI Director Dr. Norman E. Sharpless on the Death of Senator John McCain buff.ly/2wl8BnV
NCI-led research team develops predictor for immunotherapy response in melanoma buff.ly/2wgO82L
Rosenberg, NCI-supported researchers to receive 2018 Albany Prize buff.ly/2vIrH70
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer buff.ly/2B9n1fE
NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men buff.ly/2zOgjeu
NCI and VA collaborate to boost veterans’ access to cancer clinical trials buff.ly/2NCq0zs
New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments buff.ly/2JtrexC
NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies buff.ly/2Jit9lG
TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy buff.ly/2LTuEbv
NCI study finds gut microbiome can control antitumor immune function in liver buff.ly/2IItmOB
Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized buff.ly/2IYnjZK
